Faculty of Health Sciences

Permanent URI for this communityhttps://wiredspace.wits.ac.za/handle/10539/8707

For queries relating to content and technical issues, please contact IR specialists via this email address : openscholarship.library@wits.ac.za, Tel: 011 717 4652 or 011 717 1954

Browse

Filters

20141

Settings

Author: search.filters.author.Conradie, FSubject: search.filters.subject.Bedaquiline

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Clinical access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis
    (2014-03) Conradie, F; Meintjies, G; Hughes, J; et al
    While clinical disease caused by drug-sensitive Mycobacterium tuberculosis (MTB) can usually be treated successfully, clinical disease caused by drug-insensitive MTB is associated with a poorer prognosis. In December 2012, a new drug, bedaquiline, was approved by the US Food and Drug Administration. This article documents the process whereby the National Department of Health, Right to Care and Médecins Sans Frontières obtained access to this medication for South Africans who might benefit from subsequent implementation of the Clinical Access to Bedaquiline Programme.